179 related articles for article (PubMed ID: 22785236)
1. The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome.
Senda M; Ogawa S; Nako K; Okamura M; Sakamoto T; Ito S
Endocr J; 2012; 59(10):889-94. PubMed ID: 22785236
[TBL] [Abstract][Full Text] [Related]
2. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
[TBL] [Abstract][Full Text] [Related]
3. The effects of glucagon-like peptide (GLP)-1 receptor agonists on weight and glycaemic control in Prader-Willi syndrome: A systematic review.
Ng NBH; Low YW; Rajgor DD; Low JM; Lim YY; Loke KY; Lee YS
Clin Endocrinol (Oxf); 2022 Feb; 96(2):144-154. PubMed ID: 34448208
[TBL] [Abstract][Full Text] [Related]
4. Improvement in glycaemic parameters using SGLT-2 inhibitor and GLP-1 agonist in combination in an adolescent with diabetes mellitus and Prader-Willi syndrome: a case report.
Candler T; McGregor D; Narayan K; Moudiotis C; Burren CP
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):951-955. PubMed ID: 32447330
[TBL] [Abstract][Full Text] [Related]
5. Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome.
Salehi P; Hsu I; Azen CG; Mittelman SD; Geffner ME; Jeandron D
Pediatr Obes; 2017 Jun; 12(3):221-228. PubMed ID: 27071367
[TBL] [Abstract][Full Text] [Related]
6. Effects of Semaglutide on Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report.
Sani E; Prato GD; Zenti MG; Bordugo A; Trombetta M; Bonora E
Endocr Metab Immune Disord Drug Targets; 2022; 22(10):1053-1057. PubMed ID: 35538810
[TBL] [Abstract][Full Text] [Related]
7. AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial.
Allas S; Caixàs A; Poitou C; Coupaye M; Thuilleaux D; Lorenzini F; Diene G; Crinò A; Illouz F; Grugni G; Potvin D; Bocchini S; Delale T; Abribat T; Tauber M
PLoS One; 2018; 13(1):e0190849. PubMed ID: 29320575
[TBL] [Abstract][Full Text] [Related]
8. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
[TBL] [Abstract][Full Text] [Related]
9. Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes.
Inoue K; Maeda N; Kashine S; Fujishima Y; Kozawa J; Hiuge-Shimizu A; Okita K; Imagawa A; Funahashi T; Shimomura I
Cardiovasc Diabetol; 2011 Dec; 10():109. PubMed ID: 22132774
[TBL] [Abstract][Full Text] [Related]
10. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment.
Höybye C; Barkeling B; Espelund U; Petersson M; Thorén M
Growth Horm IGF Res; 2003 Dec; 13(6):322-7. PubMed ID: 14624765
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes.
Fujishima Y; Maeda N; Inoue K; Kashine S; Nishizawa H; Hirata A; Kozawa J; Yasuda T; Okita K; Imagawa A; Funahashi T; Shimomura I
Cardiovasc Diabetol; 2012 Sep; 11():107. PubMed ID: 22973968
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide therapy in Prader-Willi syndrome.
Cyganek K; Koblik T; Kozek E; Wojcik M; Starzyk J; Malecki MT
Diabet Med; 2011 Jun; 28(6):755-6. PubMed ID: 21388446
[No Abstract] [Full Text] [Related]
13. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
Höybye C
Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
[TBL] [Abstract][Full Text] [Related]
14. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome.
Kuppens RJ; Diène G; Bakker NE; Molinas C; Faye S; Nicolino M; Bernoux D; Delhanty PJ; van der Lely AJ; Allas S; Julien M; Delale T; Tauber M; Hokken-Koelega AC
Endocrine; 2015 Dec; 50(3):633-42. PubMed ID: 25989955
[TBL] [Abstract][Full Text] [Related]
15. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome.
DelParigi A; Tschöp M; Heiman ML; Salbe AD; Vozarova B; Sell SM; Bunt JC; Tataranni PA
J Clin Endocrinol Metab; 2002 Dec; 87(12):5461-4. PubMed ID: 12466337
[TBL] [Abstract][Full Text] [Related]
16. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.
Sze L; Purtell L; Jenkins A; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1314-9. PubMed ID: 21632815
[TBL] [Abstract][Full Text] [Related]
17. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
Goldstone AP; Holland AJ; Butler JV; Whittington JE
Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
[TBL] [Abstract][Full Text] [Related]
18. Elevated fasting plasma ghrelin in prader-willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance.
Goldstone AP; Thomas EL; Brynes AE; Castroman G; Edwards R; Ghatei MA; Frost G; Holland AJ; Grossman AB; Korbonits M; Bloom SR; Bell JD
J Clin Endocrinol Metab; 2004 Apr; 89(4):1718-26. PubMed ID: 15070936
[TBL] [Abstract][Full Text] [Related]
19. Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia.
Kweh FA; Miller JL; Sulsona CR; Wasserfall C; Atkinson M; Shuster JJ; Goldstone AP; Driscoll DJ
Am J Med Genet A; 2015 Jan; 167A(1):69-79. PubMed ID: 25355237
[TBL] [Abstract][Full Text] [Related]
20. Serum Ghrelin and Glucagon-like Peptide 1 Levels in Children with Prader-Willi and Bardet-Biedl Syndromes.
Türkkahraman D; Tekin S; Güllü M; Aykal G
J Clin Res Pediatr Endocrinol; 2024 May; 16(2):146-150. PubMed ID: 38099591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
